Quantification of Debris Captured Using TCEP During VIV TAVR With BVF
Part of paid clinical trials in Kansas City, Missouri.
- Sponsor
- Saint Luke's Health System
- Study ID
- NCT05093764
- Status
- Recruiting
Conditions
- Aortic Valve Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- VIV TAVR with BVF using TCEP — DEVICEThe insertion and retrieval of the SENTINEL device is performed at the time of the patients TAVR procedure in the same setting while they are sedated under moderate sedation or general anesthesia depending on the case. The device is inserted at the initiation of the procedure through 6F right radial artery access and the filters are positioned in the left common carotid artery and brachiocephalic artery. After deployment, the usual TAVR procedure is performed. At the conclusion of the procedure, the SENTINEL device is extracted and hemostasis is achieved at the radial access site in the usual fashion with patent hemostasis.
Study Details
The objective of this study is to quantify the amount of debris captured by the SENTINEL transcatheter cerebral embolic protection (TCEP) device in patients undergoing valve in valve transcatheter aortic valve replacement (VIV TAVR) with bioprosthetic valvular fracture (BVF)
Key Dates
- Start date
- Mar 2, 2022
- Status verified
- Jun 2024
- Primary completion
- Dec 31, 2024
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Other: VIV TAVR with BVF using TCEPAll subjects will receive the intervention.
Primary Outcome Measure
Quantity of debris [ Time Frame: During surgical procedure ]
Central Contacts
- Sheila Erwin, RN816-932-7996
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Saint Luke's Hospital of Kansas City | Kansas City | Missouri | 64111 | Adnan Chhatriwalla, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Kansas City, MO
By research site
Related Studies
- ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve ImplantationEnrolling By Invitation · Abbott Medical Devices · Birmingham, Alabama
- The JenaValve ALIGN-AR LVAD RegistryRecruiting · JenaValve Technology, Inc. · Los Angeles, California
- Valved Graft PMCF StudyRecruiting · Abbott Medical Devices · Birmingham, Alabama
- Prospective Long-Term Outcomes of a Standardized Ross ProcedureRecruiting · Baylor Research Institute · Plano, Texas